BHF’s HIF funds five heart research projects over £800,000
Cardiovascular diseases currently affect around seven million people in the UK, including coronary heart disease
Read More
Tag: Imperial College London
EPSRC launches two new hubs to transform early disease diagnosis in the UK
Quantum-based technologies will explore infectious diseases, cancer and dementia
Read More
ICL study finds single bowel screening test can reduce chances of developing cancer
Affecting over 250,000 people, bowel cancer is the fourth most common cancer in the UK
Read More
Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments
Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer
Read More
ICL granted £150,000 to explore link between breast cancer and breastfeeding
Breast cancer is the most common cancer in the UK, accounting for 15% of all cancers
Read More
Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease
The neurodegenerative condition currently affects around 153,000 people in the UK
Read More
ICL receives £10m donation to advance heart and lung research
The donation will help scientists and clinicians collaborate and make new advances in research
Read More
BHF awards £35m funding to nine UK universities for cardiovascular disease
Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation
Read More
Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK
Read More
UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
More than 3,000 people in England were affected by Strep A between September 2022 and May 2023
Read More
Researchers reveal COVID-19 could have small impacts on cognition and memory
Different factors, such as illness duration and virus variant, impacted patients cognitive abilities
Read More
ICL uses AI to help doctors assess lung cancer from ‘virtual biopsies’
TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
